Compare Hims and Hers Health Inc (HIMS) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

Virgin Galactic (SPCE) trades at $2.58, up 0.78% on the day, amid a bearish technical outlook and deeply negative profitability. The company continues to post significant losses, with a net income margin of -19,781.3% in 2025 and negative cash flow from operations. Recent news highlights volatility in the space sector, with SPCE shares reacting to broader industry movements and specific corporate actions like stock awards.

The outlook remains highly speculative, with substantial execution risks and cash burn posing challenges. Investment opportunity hinges on future commercialization success, but current fundamentals and analyst divergence suggest caution. Key risks include reliance on future funding and intense competition in the space tourism sector.